Skip to main content

Table 2 Characteristics of patients and their MGMT promoter methylation status determined by HRM, MSP, and PSQ in 65 IDH1 wt malignant gliomas

From: MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response

Characteristics

n

HRM me (%)

MSP me (%)

PSQ me (%)

All patients

65

41.5

30.8

46.2

Woman

22

40.9

31.8

40.9

Man

43

41.9

30.2

48.8

Age ≥70

27

44.4

25.9

44.4

Age <70

38

39.5

34.2

47.4

Grade III

7

42.9

42.9

42.9

Grade IV

58

41.4

29.3

46.6